Navigation Links
Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
Date:2/6/2008

PALO ALTO, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its fourth quarter and full year 2007 financial results on Wednesday, February 13, 2008, following the close of the U.S. financial markets. Jazz Pharmaceuticals will host an investor conference call and live audio webcast to discuss the results and company updates on February 13, 2008, at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The live webcast and press release may be accessed on Jazz Pharmaceuticals' website at http://www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available through February 27, 2008.

Investors may participate in the conference call by dialing 1-800-299-0148 in the U.S., or 1-617-801-9711 outside the U.S., and entering passcode 72272011. A replay of this call will be available until February 27, 2008 at 1-888-286-8010 or 1-617-801-6888 (international), using the passcode 23908777.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.fulldisclosure.com and institutional investors can access the call via http://www.streetevents.com.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information, please visit http://www.jazzpharmaceuticals.com .


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... women, getting birth control isn’t as easy as it should be. In fact, millions of ... health care facility or a pharmacy within 60 minutes of where they live. This is ... who are faced with health or personal issues that leave them homebound. To help facilitate ...
(Date:3/28/2017)... , ... March 29, 2017 , ... ... leading thyroid pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched ... besides answering common questions regarding thyroid function. , Dr. Izabella Wentz is ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... by physicians, announced today the launch of a free, public-facing tool for analyzing ... Analyzer (VCA) was developed to provide comparative information to patients, providers, insurers and ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business ... has begun to serve as its new executive director. Mr. Still was selected through ... Committee. , “Bob, as he is known to our members, has been a ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in ... quality care can be limited while the desire to conquer breakouts and eliminate skincare ... care for every customer online, today released its inaugural survey on the State of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... March 28, 2017  Rosen Law Firm, a global ... class action lawsuit on behalf of purchasers of Kitov ... pursuant and/or traceable to Kitov,s initial public offering on ... the open market from November 20, 2015 through February ... lawsuit seeks to recover damages for Kitov investors under ...
(Date:3/28/2017)... , March 28, 2017 ... Pharmaceutical Marketing Strategies: Digital as a Key Component ... the changing pharmaceutical marketing landscape in the digital ... new technologies to provide medical advancements, it has ... marketing efforts, mostly relying on traditional channels and ...
Breaking Medicine Technology: